Moyamoya disease: current concepts and future perspectives (Q37305024)

19 August 2017

1 reference

title

Moyamoya disease: current concepts and future perspectives (English)

1 reference

19 August 2017

1 reference

Satoshi Kuroda

1

1 reference

PubMed ID

18940695

19 August 2017

Kiyohiro Houkin

series ordinal

2

1 reference

19 August 2017

1 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

7

1 reference

19 August 2017

1056-1066

1 reference

19 August 2017

11

1 reference

Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Novel epidemiological features of moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Worldwide Distribution of Moyamoya Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Moyamoya disease in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

A survey of moyamoya disease in Hawaii

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Moyamoya disease in Washington State and California

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Moyamoya disease in Europe, past and present status

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Familial occurrence of moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Clinical features of familial moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

1 reference

7 January 2021

Role of basic fibroblast growth factor in the pathogenesis of moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Caspase-3-dependent Apoptosis in Middle Cerebral Arteries in Patients with Moyamoya Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral haemorrhage in Moyamoya disease at autopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Histopathology of the brain vascular network in moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Angiogenic factors in moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Elevation of CRABP-I in the Cerebrospinal Fluid of Patients With Moyamoya Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Current state of study on moyamoya disease in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

The relationship between moyamoya disease and bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Linkage analysis of moyamoya disease on chromosome 6

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Linkage of Familial Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis) to Chromosome 17q25

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

A novel susceptibility locus for moyamoya disease on chromosome 8q23

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral revascularization using omental transplantation for childhood moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Study of the posterior circulation in moyamoya disease. Part 2: Visual disturbances and surgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

A case of moyamoya disease presenting with chorea.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Neuropsychological recovery from childhood moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Determinants of intellectual outcome after surgical revascularization in pediatric moyamoya disease: a multivariate analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Moyamoya disease in a patient with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Effectiveness of carbamazepine for benzodiazepine-resistant impulsive aggression in a patient with frontal infarctions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Electroencephalographic Findings in Children With Moyamoya Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Evaluation of cerebral blood flow and metabolism in childhood moyamoya disease: an investigation into "re-build-up" on EEG by positron CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Regional cerebral hemodynamics during re-build-up phenomenon in childhood moyamoya disease. An analysis using 99mTc-HMPAO SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral hypoxia after hyperventilation causes "re-build-up" phenomenon and TIA in childhood moyamoya disease. A near-infrared spectroscopy study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral hemodynamics and "re-build-up" phenomenon on electroencephalogram in children with moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Source localization of the re-build up phenomenon in pediatric moyamoya disease-a dipole distribution analysis using MEG and SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

A source of haemorrhage in adult patients with moyamoya disease: the significance of tributaries from the choroidal artery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Characteristics of intracranial aneurysms associated with moyamoya disease. A review of 111 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral blood flow findings in moyamoya disease in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Subarachnoid hemorrhage not due to ruptured aneurysm in moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Moyamoya disease presenting with subarachnoid hemorrhage localized over the frontal cortex: case report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Neovascularization (angiogenesis) after revascularization in moyamoya disease. Which technique is most useful for moyamoya disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Moyamoya disease: diagnostic accuracy of MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

High-field magnetic resonance imaging in patients with moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Prevalence of asymptomatic microbleeds in patients with moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Histological analysis of microbleed after surgical resection in a patient with moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Familial occurrence of moyamoya disease. Magnetic resonance angiography as a screening test for high-risk subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Diagnosis of moyamoya disease with magnetic resonance angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

MRI and MR angiography in moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Novel magnetic resonance angiography stage grading for moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral blood flow in moyamoya disease. Part 1: Correlation with age and regional distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral blood flow in children with spontaneous occlusion of the circle of Willis (moyamoya disease): comparison with healthy children and evaluation of annual changes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Regional cerebral hemodynamics in childhood moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral blood flow in moyamoya disease. Part 2: Autoregulation and CO2 response

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral hemodynamics and metabolism in moyamoya disease--a positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral hemodynamic change in the child and the adult with moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Comparison of positron emission tomography study results of cerebral hemodynamics in patients with bleeding- and ischemic-type moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Direct revascularization to the anterior cerebral artery territory in patients with moyamoya disease: report of five cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral blood flow measurement as an indicator for an indirect revascularization procedure for adult patients with moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Preoperative and postoperative mapping of cerebrovascular reactivity in moyamoya disease by using blood oxygen level-dependent magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Adult-Onset Moyamoya Disease With Repetitive Ischemic Attacks Successfully Treated by Superficial Temporal-Middle Cerebral Artery Bypass. Case Report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Chronic low-perfusion state in children with moyamoya disease following revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Treatment of moyamoya disease with STA-MCA anastomosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Simultaneous superficial temporal artery to middle cerebral or anterior cerebral artery bypass with pan-synangiosis for Moyamoya disease covering both anterior and middle cerebral artery territories

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Superficial temporal artery to anterior cerebral artery direct anastomosis in patients with moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Direct and combined revascularization in pediatric moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Temporary neurological deterioration caused by hyperperfusion after extracranial-intracranial bypass--case report and study of cerebral hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Intraoperative measurement of arterial blood flow using a transit time flowmeter: monitoring of hemodynamic changes during cerebrovascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

A new surgical treatment of moyamoya disease in children: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

A surgical treatment of "moyamoya" disease "encephalo-myo synangiosis".

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Surgical treatment of moyamoya disease: operative technique for encephalo-duro-arterio-myo-synangiosis, its follow-up, clinical results, and angiograms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Multiple burr-hole operation for adult moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Indirect revascularisation for paediatric moyamoya disease: the EDAMS technique

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Peri-operative complications in adult moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Surgical treatment of moyamoya disease in pediatric patients--comparison between the results of indirect and direct revascularization procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Surgical treatment of childhood moyamoya disease--comparison of reconstructive surgery centered on the frontal region and the parietal region

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Long-term outcomes of pediatric moyamoya disease monitored to adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Serial intelligence test scores in pediatric moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Clinical and angiographic follow-up of childhood-onset moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Clinical features and outcome in North American adults with moyamoya phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Natural history of moyamoya disease: comparison of activity of daily living in surgery and non surgery groups.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Long-term natural history of hemorrhagic moyamoya disease in 42 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-Up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Cerebral ischemic complications following intracranial bleeding in patients with moyamoya disease--three case reports.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Long-term follow-up study of patients with unilateral moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Follow-up study of patients with "unilateral" moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Progression of unilateral moyamoya disease: A clinical series.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Progression of disease in unilateral moyamoya syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Incidence and clinical features of disease progression in adult moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Long-term outcome after STA-MCA anastomosis for moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Clinical features of moyamoya disease in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Encephaloduroarteriosynangiosis with bifrontal encephalogaleo(periosteal)synangiosis in the pediatric moyamoya disease: the surgical technique and its outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Mental outcome following encephaloduroarteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis ("moyamoya" disease) in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Combined direct anastomosis and encephaloduroarteriogaleosynangiosis using inverted superficial temporal artery-galeal flap and superficial temporal artery-galeal pedicle in adult moyamoya disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Management of adult moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset--the Japan Adult Moyamoya Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970240-0

7 January 2021

10.1016/S1474-4422(08)70240-0

Identifiers

DOI

1 reference

release_ftlyjk6zezfkzfrn3ekple6dxu

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ftlyjk6zezfkzfrn3ekple6dxu

24 November 2022

mapped directly with Wikidata item

PubMed ID

18940695

1 reference

PubMed ID

18940695